Novavax Prices $300M of Convertible Senior Notes Due 2023

By: via Benzinga
Novavax, Inc. (Nasdaq: NVAX) today announced the pricing of $300 million aggregate principal amount of convertible senior unsecured ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.